This document provides information on upper urinary tract infections from the Department of Urology at Govt Royapettah Hospital and Kilpauk Medical College in Chennai, India. It defines upper urinary tract infections and various related conditions like pyelonephritis, renal abscesses, perinephric abscesses, and pyonephrosis. It discusses the pathogenesis, clinical presentation, diagnostic evaluation, and management of these conditions. Key pathogenic bacteria are outlined and imaging findings for various infections are described. Treatment involves antibiotic therapy and sometimes drainage or nephrectomy.
Please find the power point on Renal and bladder stones. I tried present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Renal and bladder stones. I tried present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Symptomatic presence of micro-organisms within the urinary tract i.e., kidney, ureters, bladder and urethra.
• Associated with inflammation of urinary tract.
Congenital anomalies of the kidney and urinary tractDhanya Raghu
CAKUT are a group of phenotypically diverse structural malformations characterized by defects in renal and urinary tract development.
Nearly half of children who develop end-stage renal disease (ESRD) have asymmetric, irregularly shaped kidneys, often referred to as bilateral renal scarring and frequently associated with lower urinary tract anomalies, including vesicoureteral reflux (VUR).
Congenitally abnormal kidneys may be large or small, cystic or irregular in outline, and absent or misplaced.
Symptomatic presence of micro-organisms within the urinary tract i.e., kidney, ureters, bladder and urethra.
• Associated with inflammation of urinary tract.
Congenital anomalies of the kidney and urinary tractDhanya Raghu
CAKUT are a group of phenotypically diverse structural malformations characterized by defects in renal and urinary tract development.
Nearly half of children who develop end-stage renal disease (ESRD) have asymmetric, irregularly shaped kidneys, often referred to as bilateral renal scarring and frequently associated with lower urinary tract anomalies, including vesicoureteral reflux (VUR).
Congenitally abnormal kidneys may be large or small, cystic or irregular in outline, and absent or misplaced.
Recurrent bacteriuria in pregnancy is common and a serious cause of maternal and perinatal morbidity and mortality.
Clinical presentations include asymptomatic bacteriuria, acute cystitis and pyelonephritis.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
1. Upper urinary tract infection
Dept of Urology
Govt Royapettah Hospital and Kilpauk Medical College
Chennai
1
2. Moderators:
Professors:
• Prof. Dr. G. Sivasankar, M.S., M.Ch.,
• Prof. Dr. A. Senthilvel, M.S., M.Ch.,
Asst Professors:
• Dr. J. Sivabalan, M.S., M.Ch.,
• Dr. R. Bhargavi, M.S., M.Ch.,
• Dr. S. Raju, M.S., M.Ch.,
• Dr. K. Muthurathinam, M.S., M.Ch.,
• Dr. D. Tamilselvan, M.S., M.Ch.,
• Dr. K. Senthilkumar, M.S., M.Ch.
Dept of Urology, GRH and KMC, Chennai. 2
3. Definition
• UTI is an inflammatory response of the urothelium to
bacterial invasion that is usually associated with
bacteriuria and pyuria.
• Bacteriuria is the presence of bacteria in the urine.
• Pyuria, the presence of white blood cells (WBCs) in the
urine, is generally indicative of infection and/or an
inflammatory response of the urothelium to bacteria,
stones, an indwelling foreign body, or other conditions
that can contribute to pyuria.
3
Dept of Urology, GRH and KMC, Chennai.
4. • Bacteriuria without pyuria is generally indicative
of bacterial colonization without overt infection
of the urinary tract.
• Pyuria without bacteriuria, or sterile pyuria,
warrants further evaluation.
– Eg . Recent UTI treated with antibiotics
– Steroid therapy
– Pregnancy
– GU TB
– Diabetes
4
Dept of Urology, GRH and KMC, Chennai.
5. • Uncomplicated UTI describes an infection in a healthy
patient with a structurally and functionally normal
urinary tract;
• A complicated infection is associated with factors that
increase the chance of acquiring bacteria and decrease
the efficacy of therapy.
• The urinary tract is structurally or functionally
abnormal, the host is compromised, and/or the
bacteria have increased virulence or antimicrobial
resistance.
5
Dept of Urology, GRH and KMC, Chennai.
6. Factors for complicated UTI
• Functional or anatomical abnormality of urinary tract
• Male gender
• Pregnancy
• Elderly patient
• Diabetes
• Immunosuppression
• Childhood urinary tract infection
• Recent microbial agent use
• Indwelling urinary catheter
• Instrumentation
• Hospital acquired infection
• Symptoms for more than 7 days at presentation
6
Dept of Urology, GRH and KMC, Chennai.
7. • Asymptomatic bacteriuria - a person has no signs or
symptoms of a UTI, yet bacteria are identified in a
noncontaminated urine sample.
• In women, identified in quantitative counts of greater than or
equal to 100,000 CFUs in two consecutive voided samples
that are obtained in a fashion that minimizes contamination.
• In men, only one clean catch voided sample that identifies
one bacterial species in quantitative counts greater than or
equal to 100,000 CFUs is enough for asymptomatic
bacteriuria.
7
Dept of Urology, GRH and KMC, Chennai.
8. • A first or isolated infection is one that occurs
in an individual who has never had a UTI or
has one remote infection from a previous UTI.
• An unresolved infection is one that has not
responded to antimicrobial therapy and is
documented to be the same organism with a
similar resistance profile.
8
Dept of Urology, GRH and KMC, Chennai.
9. • A recurrent infection is one that occurs after
documented, successful resolution of an
antecedent infection. Two types of recurrent
infection:
1. Reinfection describes a new event associated
with reintroduction of bacteria into the urinary
tract.
2. Bacterial persistence refers to a recurrent UTI
caused by the same bacteria reemerging from a
focus within the urinary tract, such as an
infectious stone or the prostate.
9
Dept of Urology, GRH and KMC, Chennai.
10. • Domiciliary or outpatient UTIs occur in patients
who are not hospitalized or institutionalized at
the time they become infected.
• Nosocomial or health care–associated UTIs
occur in patients who are hospitalized or
institutionalized.
• Catheter-associated UTIs (CAUTIs) occur within
that population of patients with indwelling
bladder drainage catheters.
10
Dept of Urology, GRH and KMC, Chennai.
11. • Antimicrobial prophylaxis (AP) is the
attempted prevention of reinfections of the
urinary tract by the administration of
antimicrobial drugs.
• Antimicrobial suppression is the attempted
prevention of growth of a focus of bacterial
persistence that cannot be eradicated.
11
Dept of Urology, GRH and KMC, Chennai.
12. INCIDENCE & EPIDEMIOLOGY
• UTIs are the most common bacterial infection and, as
such, make a significant impact on health care costs.
• The incidence of bacteriuria increases with
institutionalization/hospitalization,
pregnancy ,
certain comorbidities ,
immunosuppression.
• No clear association between recurrent uncomplicated UTIs
and renal sequelae such as scarring,hypertension, or
progressive renal insufficiency.
12
Dept of Urology, GRH and KMC, Chennai.
13. PATHOGENESIS
• UTIs occur as a result of interactions between
the uropathogen and the host.
• Successful infection of the urinary tract is
determined in part by the virulence factors of
the bacteria, the inoculum size, and the
inadequacy of host defense mechanisms.
13
Dept of Urology, GRH and KMC, Chennai.
15. Routes of Infection
Ascending Route
• Most bacteria enter the urinary tract from the bowel and skin
reservoir via ascent through the urethra into the bladder.
• Adherence of pathogens to the introital and urothelial mucosa plays a
significant role in ascending infections.
• Most episodes of pyelonephritis are caused by retrograde
ascent of bacteria from the bladder through the ureter to the renal
pelvis and parenchyma.
• Although reflux of urine is probably not required for ascending
infections, edema associated with cystitis may cause sufficient changes
in the ureterovesical junction to permit reflux. 15
Dept of Urology, GRH and KMC, Chennai.
16. Hematogenous Route
• Uncommon route
• Occassionally secondarily infected in patients with
Staphylococcus aureus bacteremia originating from oral sites
or with Candida fungemia.
Lymphatic Route
• Direct extension of bacteria from the adjacent organs via
lymphatics may occur in unusual circumstances, such as a
severe bowel infection or retroperitoneal abscesses.
16
Dept of Urology, GRH and KMC, Chennai.
17. Urinary Pathogens
• Most UTIs are caused by facultative anaerobes usually originating
from the bowel flora.
• Uropathogens such as Staphylococcus epidermidis and Candida
albicans originate from the flora of the vagina or perineal skin.
• E. coli is by far the most common cause of UTIs, accounting for
85% of community-acquired and 50% of hospital-acquired
infections.
• Gram-negative Enterobacteriaceae, eg. Proteus and Klebsiella,
• Gram-positive Enterococcus faecalis and Staphylococcus
saprophyticus are responsible for the remainder of most
community-acquired infections.
17
Dept of Urology, GRH and KMC, Chennai.
18. • E. coli sequence type ST131 (serotype O25b:H4)
merits special attention as a rapidly emerging
cause of multidrug-resistant infections, including
UTI.
• The prevalence of infecting organisms is
influenced by the patient’s age.
18
Dept of Urology, GRH and KMC, Chennai.
19. Upper urinary tract infection
Pyelonephritis
Renal abscess
Perinephritic abscess
Emphasematous pyelonephritis
Pyonephrosis
Xanthogranulomatous pyelonephritis
TB
Renal Malakoplakia
Other Infection
19
Dept of Urology, GRH and KMC, Chennai.
20. Acute pyelonephritis
Clinically presentation:
• classical triad:
Abrupt onset fever
Chills
Flank pain / costovertebral angle pain and/or tenderness
• sometimes accompanied by dysuria, increased
urinary frequency and urgency
20
Dept of Urology, GRH and KMC, Chennai.
21. Acute pyelonephritis
Laboratory Diagnosis.
• Leukocytosis with a predominance of neutrophils.
• Urinalysis usually reveals numerous WBCs, often in clumps,
and bacterial rods or chains of cocci.
• The presence of large amounts of granular or leukocyte
casts in the urinary sediment is suggestive of acute
pyelonephritis.
Bacteriology
• Urine cultures are positive, but about 20% of patients
have urine cultures with fewer than 105 CFU/mL and
therefore negative results on Gram staining of the urine.
21
Dept of Urology, GRH and KMC, Chennai.
22. Acute pyelonephritis
Imaging
Usuallynot necessary (if uncomplicated PN)
Reasons to image
Uncertain diagnosis
Severe symptoms
Atypical clinical situation
eg male gender , unresolving infecrtion, children, diabetics
Ruled out obstruction
Evaluate source in recurrent pyelonephritis
Maysee incidentally
22
Dept of Urology, GRH and KMC, Chennai.
23. Acute pyelonephritis
USG:
• Ultrasound may show
focal parenchymal
swelling and regions
of increased or
decreased
echogenicity
Ultrasound of acute pyelonephritis.
Arrows show abnormally
echogenic and swollen upper pole
23
Dept of Urology, GRH and KMC, Chennai.
24. Acute pyelonephritis
• CT and MRI also
may show focal
swelling and
diminished and in
homogeneous
parenchymal
contrast
enhancement.
Computed tomography of focal pyelonephritis.
Arrows show patchy regions of diminished
heterogeneousenhancement and swelling.
24
Dept of Urology, GRH and KMC, Chennai.
25. Acute pyelonephritis
• Management.
Acute pyelonephritis subdivided into
(1) uncomplicated infection that does not warrant
hospitalization,
(2) uncomplicated infection in patients with normal urinary
tracts who are ill enough to warrant hospitalization for
parenteral therapy, and
(3) complicated infection associated with hospitalization,
catheterization, urologic surgery, or urinary tract
abnormalities
25
Dept of Urology, GRH and KMC, Chennai.
28. Renal abscess
• Renal abscess or carbuncle is a collection of purulent
material confined to the renal parenchyma.
• Before the antimicrobial era, 80% of renal abscesses were
attributed to hematogenous seeding by Staphylococci.
• Since about 1970, gram-negative organisms have been
implicated in the majority of adults with renal abscesses.
• The most common organisms include E. coli, Klebsiella,
Proteus, and Pseudomonas spp.
28
Dept of Urology, GRH and KMC, Chennai.
29. Renal abscess
Clinical presentation:
• fever,
• chills,
• abdominal or flank pain, and
• occasionally weight loss and malaise
29
Dept of Urology, GRH and KMC, Chennai.
30. Renal abscess
Laboratory finding.
• The patient typically has marked leukocytosis.
• Because gram-positive organisms are most
commonly blood-borne, urine cultures in
these cases typically show no growth or a
microorganism different from that isolated
from the abscess.
30
Dept of Urology, GRH and KMC, Chennai.
31. Renal abscess
Imaging:
• USG is the quickest and least
expensive.
• Rounded, thick wall cystic
mass with debris
• An echo-free or low-
echodensity space-
occupying lesion with
increased transmission
is found.
Transverse ultrasound image of the right
kidney demonstratesa poorly marginated
rounded focal hypoechoic mass (arrows) in
the anteriorportion of the kidney. 31
Dept of Urology, GRH and KMC, Chennai.
32. Renal abscess
• CT -diagnostic procedure of choice
because it provides excellent
delineation of the tissue.
• On CT, abscesses are
characteristically well defined
before and after contrast agent
enhancement. The findings
depend in part on the age and
severity of the abscess.
NCCT scan- mid pole of the right
kidney demonstratesright renal
enlargement and an area of decreased
attenuation(arrows). 32
Dept of Urology, GRH and KMC, Chennai.
33. Chronic renal abscess
computed tomography scan shows an irregular septated
low-density mass (M) extensively involving the left kidney.
Note thickening of perinephric fascia and extensive
compression of the renal collecting system. Findings are
typical of renal abscess. 33
Dept of Urology, GRH and KMC, Chennai.
34. Renal abscess
Management
• IV antibiotic therapy
• Percutaneous or open incision and drainage
• Nephrectomy (rare)
34
Dept of Urology, GRH and KMC, Chennai.
36. Perinephric Abscess
• It extends beyond the renal capsule but is contained by
Gerota fascia.
• When a perinephric infection ruptures through the Gerota
fascia into the pararenal space, the abscess becomes
paranephric.
• Diabetes mellitus is present in approximately one-third of
patients.
• E. coli, Proteus, and S. aureus account for most infections
36
Dept of Urology, GRH and KMC, Chennai.
37. Perinephric Abscess
• Cause:
– rupture of an acute cortical abscess into the perinephric
space,
– Extravasated infected urine from obstruction,
– hematogenous seeding from sites of infection
(mostly by skin infection)
- Adjacent organ infection (IBD, thoracolumber spine
Osteomyelitis, bowel perforation)
37
Dept of Urology, GRH and KMC, Chennai.
38. Perinephric Abscess
• Clinically presentation like pyelonephritis only.
• Sometimes palpable mass present.
• After giving 4-5 days antibiotics- symptoms
not subsiding then think about abscess.
38
Dept of Urology, GRH and KMC, Chennai.
39. Perinephric Abscess
CT is particularly valuable for
demonstrating the primary
abscess.
NCCT- the lower pole of the right kidney (previous
left nephrectomy)shows extensive perinephric
abscess. Extensiveabscess distortsand enlarges the
renal contour, infiltratesperinephric fat and extends
into the psoas muscle (asterisk) and the soft tissues
of the flank. 39
Dept of Urology, GRH and KMC, Chennai.
40. Perinephric abscess
Management:
• IV antibiotics
• Percutaneous/ open drainage
if size - > 3cms
• Nephrectomy (rare)- if kidney severely
infected or non functioning.
40
Dept of Urology, GRH and KMC, Chennai.
41. Pyonephrosis
• Infected hydronephrosis is bacterial infection in a
hydronephrotic kidney.
• The term pyonephrosis refers to infected hydronephrosis
associated with suppurative destruction of the parenchyma of
the kidney, in which there is total or nearly total loss of renal
function.
Clinical presentation:
• very ill
• High fever,
• chills
• flank pain
• tenderness 41
Dept of Urology, GRH and KMC, Chennai.
42. Pyonephrosis
Radiologic Findings.
• USG- internal echoes, fluid debris within the
dependent portion of a dilated pyelocalyceal
system.
• CT is nonspecific but may show thickening of
the renal pelvis, stranding of the perirenal fat,
and a striated nephrogram.
42
Dept of Urology, GRH and KMC, Chennai.
43. Pyonephrosis
(A) Longitudinal ultrasound image of the right kidney demonstrates echogenic central
collectingcomplex with radiating echogenic septa (arrows)and thinned hypoechoic
parenchyma. Multiple dilated calyces (o) with diffuse low-levelechoes are seen.
(B) Antegrade pyelogram performed through a percutaneous nephrostomy catheter
correlateswell with the ultrasound image. Dilated pus-filledcalyces are demonstrated.
The renal pelvis is obliteratedby chronic scarring and stone disease.. 43
Dept of Urology, GRH and KMC, Chennai.
44. Pyonephrosis
Gross specimen. The kidney shows marked thinning of the renal
cortex and medulla, suppurative destruction of the parenchyma, and
distention of the pelvis and calyces. Previous incision released a large
quantity of purulent material. The ureter showed obstruction distal
to the point of section.
44
Dept of Urology, GRH and KMC, Chennai.
46. Emphysematous pyelonephritis
• It is a urologic emergency characterized by an acute
necrotizing parenchymal and perirenal infection caused by
gas-forming uropathogens.
• First case reported by Kelly and Maccullum in 1898 .
• Since then terms such as ‘renal emphysema’,
‘pneumonephritis’ as well as ‘emphysematous
pyelonephritis’
• In 1962, Schultz and Klorfein suggested the use of
‘emphysematous pyelonephritis’ as the preferred term.
46
Dept of Urology, GRH and KMC, Chennai.
47. Emphysematous pyelonephritis
–EPN most often occurs in persons with
diabetes mellitus especially women.
–Presentation is similar to that of acute
pyelonephritis.
–But often has a fulminating course, and can
be fatal if not recognized and treated
promptly
47
Dept of Urology, GRH and KMC, Chennai.
48. Emphysematous pyelonephritis
Epidemiology:
• Mean age of patients with EPN is 55 years, with a range of 19-
81 years.
• 6 times more common in women.
• Ninety-five percent of patients have diabetes.
• In most patients, the diabetes is uncontrolled, with high levels
of glycosylated hemoglobin (72%) or of blood sugar.
• Renal stones are another predisposing condition and
therefore affect the frequency of EPN
• Left kidney is affected more commonly than the right.
Bilateral cases have also been reported.
48
Dept of Urology, GRH and KMC, Chennai.
49. Emphysematous pyelonephritis
Other reported factors associated with the
development of EPN are
– drug abuse,
– neurogenic bladder
– Alcoholism
– anatomic anomaly like polycystic kidney disease
49
Dept of Urology, GRH and KMC, Chennai.
50. Emphysematous pyelonephritis
Etiology :
• Enteric gram-negative facultative anaerobes.
• Escherichia coli- 66% of patients, and
Klebsiella species- 26% of patients.
• Proteus, pseudomonas, and streptococcus species are other
organisms found in patients with EPN.
• Mixed organisms are observed in 10% of patients.
• Rarely, fungi (eg, aspergillus fumigatus, candida species) and
protozoa (entamoeba histolytica) have been isolated in patients
with EPN.
50
Dept of Urology, GRH and KMC, Chennai.
51. Emphysematous pyelonephritis
Pathology:
• Various factors involved in the pathogenesis of
this condition have been suggested, including
– high levels of glucose within the tissues,
– the presence of gas-forming microorganisms,
– impaired vascular blood supply,
– reduced host immunity,
– the presence of obstruction within the urinary
tract
51
Dept of Urology, GRH and KMC, Chennai.
52. Emphysematous pyelonephritis
Pathophysiology:
• Urinary tract infections are common in persons with diabetes,
• Factors that predispose to EPN in persons with diabetes may
include uncontrolled diabetes, high levels of glycosylated
hemoglobin and impaired host immune mechanisms.
• High tissue glucose levels- provide the substrate for microorganisms
such as E. Coli, producing carbon dioxide by the fermentation of
sugar
• Diabetic microangiopathy may also contribute to the slow transport
of catabolic products and may lead to accumulation of gas.
52
Dept of Urology, GRH and KMC, Chennai.
55. Emphysematous pyelonephritis
Clinical Presentation:
• Fever (79%)
• Abdominal or flank pain (71%)
• Nausea and vomiting(17%)
• Dyspnea (13%)
• Acute renal impairment (35%)
• Altered sensorium (19%)
• Shock (29%)
• Other possible findings include the following:
– Crepitus, Pneumaturia
– Subcutaneous emphysema and pneumomediastinum
55
Dept of Urology, GRH and KMC, Chennai.
56. Emphysematous pyelonephritis
Gross examination of emphysematouspyelonephritis:
(a) specimen of enlargedkidney with loss of cortex and medulla with
adherent perirenal fatty tissue (highlighted by arrow),
(b) foci of abscess within parenchyma(highlighted by arrow),
(c) abscess extending towardcapsule (highlighted by arrow)
Gross specimen
56
Dept of Urology, GRH and KMC, Chennai.
57. Emphysematous pyelonephritis
Diagnosis:
• Laboratory findings include :
– Leukocytosis
– Pyuria
– Infected urine
– Thrombocytopenia
– An elevated creatinine level
– Positive blood culture results
57
Dept of Urology, GRH and KMC, Chennai.
58. Emphysematous pyelonephritis
• May show mottled gas
within renal fossa or
• Crescentic gas collection
within gerota's fascia.
• Linear gas shadows along
paraspinal region may also
be seen, representing
retroperitoneal air.
X-Ray
58
Dept of Urology, GRH and KMC, Chennai.
59. Emphysematous pyelonephritis
•May show an enlarged kidney
with coarse echoes within
renal parenchyma or collecting
system
•Dirty echogenic foci with ring-
down artifacts representing air
('dirty shadowing') may also be
seen
USG
59
Dept of Urology, GRH and KMC, Chennai.
61. Emphysematous pyelonephritis
• Acc to Wan et al classification
Type I (dry type) has a 65-70% mortality rate
Type II (wet type) has a 15-20% mortality rate
Although transformation from type I to type II
has been observed following conservative
treatment.
61
Dept of Urology, GRH and KMC, Chennai.
62. Emphysematous pyelonephritis
Type 1
•Greater than one-third renal
parenchymal destruction
•Streaky or mottled appearance
of gas
•Intra- or Extrarenal fluid
collections are characteristically
absent
•more aggressive and lead to
death shortly, if not intervened
early
•Mortality 70%
CT Image
62
Dept of Urology, GRH and KMC, Chennai.
63. Emphysematous pyelonephritis
Type 2
•Destruction of less than one-
third of the parenchyma
•Renal or extrarenal collections
associated with bubbly or
loculated gas, or gas within
pelvicalyceal system or ureter
•Mortality 20%
63
Dept of Urology, GRH and KMC, Chennai.
66. Emphysematous pyelonephritis
Antibiotics selection:
• Class 1 – A third-generation cephalosporin, with or without
amikacin, plus percutaneous catheter drainage in patients
with obstructive uropathy
• Class 2, 3, and 4 without risk factors – A third-generation
cephalosporin, with or without amikacin, plus
percutaneous catheter drainage
• Class 2, 3, and 4 with risk factors – Carbapenem with or
without vancomycin plus percutaneous catheter drainage
66
Dept of Urology, GRH and KMC, Chennai.
67. Emphysematous pyelonephritis
• Indication of Nephrectomy:
– Treatment of choice for most patients
– No access to percutaneous drainage or internal stenting (after
patient is stabilized)
– Gas in the renal parenchyma or "dry-type" EPN
– Possibly bilateral nephrectomy in patients with bilateral EPN
– Class 3 and class 4 EPN: In the presence of more than 2 risk
factors
67
Dept of Urology, GRH and KMC, Chennai.
68. Emphysematous pyelonephritis
• Factors associated with a poor prognosis in
patients with
– Altered level of consciousness,
– multiple organ failure,
– hyperglycemia, and
– leukocytosis.
68
Dept of Urology, GRH and KMC, Chennai.
70. Chronic pyelonephritis
• In patients without underlying renal or urinary tract
disease, chronic pyelonephritis secondary to UTI is a
rare disease and an even more rare cause of chronic
renal failure.
Clinical Presentation.
– There are no symptoms of chronic pyelonephritis until it
produces renal insufficiency, and then the symptoms are
similar to those of any other form of chronic renal failure.
70
Dept of Urology, GRH and KMC, Chennai.
71. Chronic pyelonephritis
Imaging
• IVP
– asymmetry and
irregularity of the
kidney outlines,
– blunting and
dilation of one or
more calyces,
– cortical scars at the
corresponding site
cyst
71
Dept of Urology, GRH and KMC, Chennai.
73. Chronic pyelonephritis
Pathology
• In chronic pyelonephritis, the gross kidney is
often diffusely contracted, scarred, and pitted.
• The scars are Y-shaped, flat, broad-based
depressions with red-brown granular bases.
73
Dept of Urology, GRH and KMC, Chennai.
75. Xanthogranulomatous pyelonephritis
• XGPN is a rare, severe, chronic renal infection typically
resulting in diffuse renal destruction.
• Most cases are unilateral and result in a nonfunctioning,
enlarged kidney associated with obstructive uropathy
secondary to nephrolithiasis.
• It begins within the pelvis and calyces and subsequently
extends into and destroys renal parenchymal and
adjacent tissues.
• It has been known to imitate almost every other
inflammatory disease of the kidney, as well as renal cell
carcinoma, on radiographic examination. 75
Dept of Urology, GRH and KMC, Chennai.
76. Xanthogranulomatous pyelonephritis
Risk factors:
• Following nephrolithiasis (stag horn) 83%
• Increased risk in diabetics
• Following recurrent UTIs
• Urological instrumentation
• Common in 5th-7th decade
• Common in women
• No predilection for either kidney
76
Dept of Urology, GRH and KMC, Chennai.
77. Xanthogranulomatous pyelonephritis
Nephrolithiasis (stag horn)
I
obstruction
I
stasis
I
infection
I
tissue destruction
I
collection of lipid material by macrophages
I
lipid laden macrophages (xanthoma cell) are distributed in
sheets around parenchymal abscess and calyces and are
intermixed with lymphocytes ,giant cells &plasma cells.
Pathogenesis:
77
Dept of Urology, GRH and KMC, Chennai.
78. Xanthogranulomatous pyelonephritis
Gross specimen:
• (A) Gross specimen. Kidney is
massively enlarged, measuring 23 ×
12 cm; the normal architecture is
replaced by a shaggy yellow upper
pole mass corresponding to
xanthogranulomatous
inflammation and numerous
distorted and dilated calyces.
• (B) Microscopically, the shaggy
yellow tissue is composed primarily
of lipid-laden histiocytes mixed
with other inflammatory cells
78
Dept of Urology, GRH and KMC, Chennai.
79. Xanthogranulomatous pyelonephritis
On section: Macroscopically:
Kidney demonstrate:
• Nephrolithiasis
• Peripelvic fibrosis(comparatively less dilated/contracted
pelvis)
• Calyceal dilatation filled with pus
• Papillary necrosis
• Multiple parenchymal abscess (advanced disease) with
yellowish tissue & pus
• Cortex is thin often replace by Xantho granulomatous tissue
• Capsule is thickened
• Inflammatory extension into peripelvic & parapelvic space is
common
79
Dept of Urology, GRH and KMC, Chennai.
80. Xanthogranulomatous pyelonephritis
MICROSCOPIC EXAMINATION:
• Yellowish nodules line the calyces
and surrounds parenchymal
abscesses
• Contain dark sheets of lipid laden
macrophages (foamy histiocytes
with small dark nucleus & clear
cytoplasm)
• Intermixed lymphocytes, giant
cells and plasma cells
80
Dept of Urology, GRH and KMC, Chennai.
81. Xanthogranulomatous pyelonephritis
Two types
Diffuse : [80%] entire kidney is involved
Segmental :[20%] only the parenchyma
surrounding one or more calyces or one pole of
a duplicated collecting system
Staging
1- within kidney
2- within Gerota’s fascia
3- outside Gerota’s fascia
81
Dept of Urology, GRH and KMC, Chennai.
82. Xanthogranulomatous pyelonephritis
Clinical presentation:
*Flank pain (69%)
*Fever & chills (69%)
*Persistent bacteriuria(46%)
*Flank mass(62%)
*calculi(35%)
Less commonly
*Hypertension
*Hematuria
*Hepatomegaly
*Vague symptoms like malaise
82
Dept of Urology, GRH and KMC, Chennai.
83. Xanthogranulomatous pyelonephritis
Bacteriology & Lab findings:
• Proteus (most common organism involved) association with stone
formation and subsequent c/c obstruction and irritation
• Ecoli(also common)
• Anaerobes
• 10%(mixed infections)
Only 1/3 patients have a positive urine culture
URINE ANALYSIS : Shows pus &protein
BLOOD TESTS: Anemia ,hepatic dysfunction(50%) ,
Azotemia or frank renal failure uncommon( XGN- almost always U/L)
83
Dept of Urology, GRH and KMC, Chennai.
84. Xanthogranulomatous pyelonephritis
CT SCAN :
most useful
Classic triad (50-80%)
-unilateral renal enlargement
-little or no function
-large calculus in renal pelvis
• “ bear claw “ sign
• Massive caliectasis
• stone
84
Dept of Urology, GRH and KMC, Chennai.
85. Xanthogranulomatous pyelonephritis
CT SCAN :
*large reniform mass with renal pelvis tightly surrounding a
central calcification without pelvic dilatation
*Renal parenchyma is replaced by multiple water density
masses representing dilated calyces &abscess cavity
*On enhancement the walls of the cavity demonstrate a
prominent blush owing to vascularity of granulation tissue
*CT is useful to know the extent of renal involvement & also
adjacent organ or abdominal wall.
85
Dept of Urology, GRH and KMC, Chennai.
86. Xanthogranulomatous pyelonephritis
RETROGRADE PYELOGRAPHY:
• point of obstruction
• dilatation of pelvis &calyces
• ulcerated pyelocalyceal system with multiple irregular filling
defect (if extensive parenchymal damage)
USG:
• demonstrate global enlargement of the kidney
• normal architecture is replaced by multiple hypoechoic fluid
filled masses correspond to debris filled ,
• dilated calyces or foci of parenchymal destruction
86
Dept of Urology, GRH and KMC, Chennai.
87. Xanthogranulomatous pyelonephritis
RADIONUCLIDE RENAL SCANNING:
99mTC-DMSA is used
confirm differential function of the involved kidney
MRI :
not yet super seeded to CT
advantage is in delineating extrarenal extension of inflammation
T1 weighted image : appear as cystic foci of intermediate
intensity signal
T2 weighted image : hyperintensity signal
-- All radiological studies although distinctive often cannot
differentiate between XGPN & Renal cell ca
87
Dept of Urology, GRH and KMC, Chennai.
88. Xanthogranulomatous pyelonephritis
Management:
*Primary obstacle to correct treatment is incorrect diagnosis
*with CT scan preoperative diagnosis is 90%
Antimicrobial therapy
*To stabilise the patient preoperatively
*occasionally with initial stages long term antimicrobial therapy
will eradicate infection & restore renal function
Percutaneous drainage -not curative
88
Dept of Urology, GRH and KMC, Chennai.
89. Xanthogranulomatous pyelonephritis
NEPHRECTOMY
*If diagnosed preoperatively for diffuse type nephrectomy
is the treatment of choice
*For segmental involvement partial nephrectomy is
considered
LAPROSCOPIC NEPHRECTOMY
-reasonable , but high conversion rate
-recent approach
89
Dept of Urology, GRH and KMC, Chennai.
90. Renal Parenchymal Malakoplakia
• Greek word meaning “soft plaque,”
• Originally described to affect the bladder but has been found to
affect the genitourinary and gastrointestinal tracts, skin, lungs,
bones, and mesenteric lymph nodes.
• It is an inflammatory granulomatous lesion.
• described originally by Michaelis and Gutmann (1902)
• It was characterized by von Hansemann (1903) as soft, yellow-
brown plaques with lesions in which the histiocytes contain distinct
basophilic lysosomal inclusion bodies or Michaelis-Gutmann bodies.
90
Dept of Urology, GRH and KMC, Chennai.
91. Renal Parenchymal Malakoplakia
• Malacoplakia probably results from abnormal macrophage
function in response to a bacterial infection, which is most
often due to E. coli.
• It is hypothesized that bacteria or bacterial fragments form
the nidus for the calcium phosphate crystals that laminate the
Michaelis-Gutmann bodies.
91
Dept of Urology, GRH and KMC, Chennai.
92. Renal Parenchymal Malakoplakia
Pathology
• The diagnosis is made by biopsy.
• Large histiocytes, known as von
Hansemann cells
• small basophilic, extracytoplasmic,or
intracytoplasmic calculospherules
called Michaelis-Gutmann bodies,
which are pathognomonic.
• MG bodies can be absent in early
stage.
92
Dept of Urology, GRH and KMC, Chennai.
93. Renal Parenchymal Malakoplakia
• Macrophages in malacoplakia contain large amounts of α1-
antitrypsin.
• Therefore immunohistochemical staining for α1- antitrypsin
may be a useful test for an early and accurate differential
diagnosis of malacoplakia.
93
Dept of Urology, GRH and KMC, Chennai.
94. Renal Parenchymal Malakoplakia
Epidemiology:
• Most patients are older than 50 years.
• Female: male = 4:1
• Malakoplakia rarely presents in patients with HIV
infection and AIDS,which may be because of the preservation
of monocytic antimicrobial function in these patients.
• Increasingly described after solid organ transplantation,
particularly renal transplant recipients
94
Dept of Urology, GRH and KMC, Chennai.
95. Renal Parenchymal Malakoplakia
Radiologic Findings
Excretory urography
– Enlarged kidneys with multiple filling defects.
– Renal calcification, lithiasis, and hydronephrosis are absent.
Ultrasound
– renal enlargement.
– Confluent masses with increased echogenicity.
Arteriography
– typically reveals a hypovascular mass without peripheral
neovascularity.
95
Dept of Urology, GRH and KMC, Chennai.
96. Renal Parenchymal Malakoplakia
CT Findings:
• Bilateralor unilateral
• Focal, multifocalor diffuse
• Infiltratingmasses
• ± Renal pelvisinvolvement
• Uncommoncalcifications
• The foci of malacoplakia are less
dense and non enhancing than the
surrounding enhanced parenchyma .
96
Dept of Urology, GRH and KMC, Chennai.
97. Renal Parenchymal Malakoplakia
Management
• Directed at control of the UTIs with antimicrobial agents
• Sulfonamides, rifampicin, doxycycline and TMP are useful
because of their intracellular bactericidal activity.
• Fluoroquinolones have also proven effective in the
management.
• Ascorbic acid and cholinergic agents such as bethanechol in
conjunction with antimicrobial therapy have reported good
results[cGMP] . 97
Dept of Urology, GRH and KMC, Chennai.
98. Renal Parenchymal Malakoplakia
• If the disease progresses in spite of antimicrobial treatment-
then plan for Nephrectomy.
• When parenchymal renal malacoplakia is bilateral or occurs in
the transplanted kidney, death usually occurs within 6
months.
• Patients with unilateral disease usually have a long-term
survival after nephrectomy.
98
Dept of Urology, GRH and KMC, Chennai.